Edition:
India

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

13.72USD
23 Jan 2018
Change (% chg)

$0.37 (+2.77%)
Prev Close
$13.35
Open
$13.47
Day's High
$13.76
Day's Low
$13.26
Volume
301,253
Avg. Vol
252,738
52-wk High
$28.49
52-wk Low
$11.12

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $444.74
Shares Outstanding(Mil.): 32.58
Dividend: --
Yield (%): --

Financials

BRIEF-Cara Therapeutics Inc reports Q3 loss per share $0.38

* Cara Therapeutics Inc reports third quarter 2017 financial results

03 Nov 2017

BRIEF-Cara Therapeutics Q2 loss per share $0.29

* Cara Therapeutics reports second quarter 2017 financial results

04 Aug 2017

BRIEF-Cara Therapeutics appoints Mani Mohindru CFO

* Cara Therapeutics appoints Mani Mohindru, Ph.D., chief financial officer

01 Aug 2017

Earnings vs. Estimates